Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2023 Filed Sep 6, 2023 17:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 9 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:58 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 82 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017642 · form4.xml · derivative · entry 16 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 410 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 410 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:58 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 34 | $394.60 | $13,416.40 |
DisclosureSEC source: 0001062993-23-017642 · form4.xml · nonDerivative · entry 10 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,176 Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:58 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017642 · form4.xml · nonDerivative · entry 9 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:55 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017638 · form4.xml · derivative · entry 16 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F9 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F9 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:55 UTC |
MAY SIMONEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 295 | $394.60 | $116,407.00 |
DisclosureSEC source: 0001062993-23-017638 · form4.xml · nonDerivative · entry 10 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,104.9894 Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:55 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017638 · form4.xml · nonDerivative · entry 9 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,399.9894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:56 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017640 · form4.xml · derivative · entry 15 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:56 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 275 | $394.60 | $108,515.00 |
DisclosureSEC source: 0001062993-23-017640 · form4.xml · nonDerivative · entry 10 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,880.0277 Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:56 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017640 · form4.xml · nonDerivative · entry 9 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,155.0277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:52 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 16 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:52 UTC |
COREY COLLEENEVP, Global Human Resources
|
Tax withholdingBio-Rad A Common Stock | 208 | $394.60 | $82,076.80 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 10 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,223 Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:52 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 9 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:06 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 464 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017650 · form4.xml · derivative · entry 15 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 464 Underlying: Bio-Rad A Common Stock · 464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:06 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 231 | $394.60 | $91,152.60 |
DisclosureSEC source: 0001062993-23-017650 · form4.xml · nonDerivative · entry 8 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,131.7965 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:06 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017650 · form4.xml · nonDerivative · entry 7 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,362.7965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 15 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 557 Underlying: Bio-Rad A Common Stock · 557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 202 | $394.60 | $79,709.20 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 8 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,282 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 7 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:58 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 56 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017642 · form4.xml · derivative · entry 15 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56 Underlying: Bio-Rad A Common Stock · 56 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:58 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 23 | $394.60 | $9,075.80 |
DisclosureSEC source: 0001062993-23-017642 · form4.xml · nonDerivative · entry 8 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,128 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:58 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017642 · form4.xml · nonDerivative · entry 7 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:55 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 526 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017638 · form4.xml · derivative · entry 15 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526 Underlying: Bio-Rad A Common Stock · 526 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,629 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,629 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:55 UTC |
MAY SIMONEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 182 | $394.60 | $71,817.20 |
DisclosureSEC source: 0001062993-23-017638 · form4.xml · nonDerivative · entry 8 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,799.9894 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:55 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017638 · form4.xml · nonDerivative · entry 7 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,981.9894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:56 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017640 · form4.xml · derivative · entry 14 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495 Underlying: Bio-Rad A Common Stock · 495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:56 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 172 | $394.60 | $67,871.20 |
DisclosureSEC source: 0001062993-23-017640 · form4.xml · nonDerivative · entry 8 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,555.0277 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:56 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017640 · form4.xml · nonDerivative · entry 7 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,727.0277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:52 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 15 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495 Underlying: Bio-Rad A Common Stock · 495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:52 UTC |
COREY COLLEENEVP, Global Human Resources
|
Tax withholdingBio-Rad A Common Stock | 172 | $394.60 | $67,871.20 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 8 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,831 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:52 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionBio-Rad A Common Stock | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 7 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 18:28 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 903 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017654 · form4.xml · derivative · entry 10 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 903 Underlying: Bio-Rad A Common Stock · 903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 18:28 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 448 | $394.60 | $176,780.80 |
DisclosureSEC source: 0001062993-23-017654 · form4.xml · nonDerivative · entry 6 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,039.6001 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 18:28 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017654 · form4.xml · nonDerivative · entry 5 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,487.6001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:08 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017652 · form4.xml · derivative · entry 10 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434 Underlying: Bio-Rad A Common Stock · 433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:08 UTC |
WRIGHT DARAExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 150 | $394.60 | $59,190.00 |
DisclosureSEC source: 0001062993-23-017652 · form4.xml · nonDerivative · entry 6 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,681.8746 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:08 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017652 · form4.xml · nonDerivative · entry 5 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,831.8746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:06 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 361 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017650 · form4.xml · derivative · entry 14 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361 Underlying: Bio-Rad A Common Stock · 361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:06 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 179 | $394.60 | $70,633.40 |
DisclosureSEC source: 0001062993-23-017650 · form4.xml · nonDerivative · entry 6 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,898.7965 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:06 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017650 · form4.xml · nonDerivative · entry 5 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,077.7965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:04 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 241 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017648 · form4.xml · derivative · entry 9 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241 Underlying: Bio-Rad A Common Stock · 241 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:04 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Tax withholdingBio-Rad A Common Stock | 84 | $394.60 | $33,146.40 |
DisclosureSEC source: 0001062993-23-017648 · form4.xml · nonDerivative · entry 6 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403.395 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:04 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionBio-Rad A Common Stock | 241 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017648 · form4.xml · nonDerivative · entry 5 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487.395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 14 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434 Underlying: Bio-Rad A Common Stock · 433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 150 | $394.60 | $59,190.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 6 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,927 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 5 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:00 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 542 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017644 · form4.xml · derivative · entry 10 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 542 Underlying: Bio-Rad A Common Stock · 542 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:00 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Tax withholdingBio-Rad A Common Stock | 269 | $394.60 | $106,147.40 |
DisclosureSEC source: 0001062993-23-017644 · form4.xml · nonDerivative · entry 6 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,486.212 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:00 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Exercise / conversionBio-Rad A Common Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017644 · form4.xml · nonDerivative · entry 5 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,755.212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 16:58 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 44 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017642 · form4.xml · derivative · entry 14 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44 Underlying: Bio-Rad A Common Stock · 44 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.